1-bromo-7-fluoroheptane | CAS:334-42-9

We serve 1-bromo-7-fluoroheptane CAS:334-42-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
1-bromo-7-fluoroheptane

Chemical Name:1-bromo-7-fluoroheptane
CAS.NO:334-42-9
Synonyms:1-bromo-7-fluoroheptane
Heptane, 1-bromo-7-fluoro-
Molecular Formula:C7H14BrF
Molecular Weight:197.0884632
 
Physical and Chemical Properties:
Density:1.211
Boiling point:202.6ºC
Flash point:78.9ºC
Index of Refraction:1.436
 
Specification:
Appearance:Colorless transparent liquid
Assay:≥99.0%
Moisture:≤0.05%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



Contact us for information like 1-bromo-7-fluoroheptane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Heptane, 1-bromo-7-fluoro- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-bromo-7-fluoroheptane Use and application,1-bromo-7-fluoroheptane technical grade,usp/ep/jp grade.


Related News: The rigosertib Pre-approval Access Program is expected to launch in first half of 2020 and will allow Inceptua to supply intravenous rigosertib within designated countries, primarily and initially concentrated in selected countries in Europe, in response to physician requests for patients with higher-risk MDS who have exhausted all available treatment options, and are not eligible for or have no access to the INSPIRE study.3-methyl-7H-xanthine manufacturer From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity.7-Chloro-5-phenyl-1H-benzo[e]-[1,4]diazepine-2(3H)-thione supplier From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity.(2R,4S)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid vendor Profitability continued to improve. The company’s comprehensive gross profit margin for the first three quarters was 36.06%, a year-on-year increase of 3.44 percentage points. Since this year, the company’s profitability has remained at a relatively high level. On the one hand, due to the decline in the trading business with lower profitability, the proportion has declined.Profitability continued to improve. The company’s comprehensive gross profit margin for the first three quarters was 36.06%, a year-on-year increase of 3.44 percentage points. Since this year, the company’s profitability has remained at a relatively high level. On the one hand, due to the decline in the trading business with lower profitability, the proportion has declined.